Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 26:17:1659-1666.
doi: 10.2147/NDT.S291020. eCollection 2021.

CSF TNF-α Levels Were Associated with Longitudinal Change in Brain Glucose Metabolism Among Non-Demented Older People

Pan Fu  1 , Bihong Zhu  1 , Yangping Huang  1 ; Alzheimer’s Disease Neuroimaging Initiative
Affiliations

CSF TNF-α Levels Were Associated with Longitudinal Change in Brain Glucose Metabolism Among Non-Demented Older People

Pan Fu et al. Neuropsychiatr Dis Treat. .

Abstract

Purpose: Emerging studies have suggested that tumor necrosis factor-alpha (TNF-α) is implicated in the pathogenesis of Alzheimer's disease (AD), and that cerebral glucose hypometabolism is a key feature of AD. However, the association of CSF TNF-α levels with changes in cerebral glucose metabolism has not been studied among non-demented older people.

Patients and methods: At baseline, there were a total of 214 non-demented older people from Alzheimer's Disease Neuroimaging Initiative (ADNI) study. We examined the cross-sectional and longitudinal associations of CSF TNF-α with global cognition (as assessed by mini-mental state examination), verbal memory (as assessed by Rey Auditory Verbal Learning Test-total learning score), and cerebral glucose metabolism (as measured by FDF-PET). Linear mixed-effects models were used to examine the longitudinal association of CSF TNF- α with change in each outcome over time with adjustment of age, educational level, gender, and APOE4 status.

Results: In the cross-sectional study, CSF TNF-α was negatively associated with MMSE scores, but not verbal memory or FDG-PET. In the longitudinal study, higher CSF TNF- α at baseline was associated with a faster decline in cerebral glucose metabolism, but not MMSE scores or RAVLT total learning scores.

Conclusion: Higher CSF TNF-α levels were associated with a steeper decline in cerebral glucose metabolism among non-demented older people.

Keywords: Alzheimer’s disease; FDG-PET; TNF-α; cerebral glucose metabolism; mild cognitive impairment.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
Associations of CSF TNF- α with change in AD-related markers over time. Higher CSF TNF-α levels were associated with a faster decline in FDG SUVR (estimate = −0.0089, se= 0.0043, p value = 0.0385, (C) but not MMSE scores (estimate = −0.1246, se= 0.1592, p value = 0.4341, (A) or RAVLT total learning scores (estimate = 0.0105, se= 0.2333, p value = 0.9641, (B).
Figure 2
Figure 2
Associations of CSF TNF- α with change in FDG SUVR over time in the amyloid negative MCI subjects and amyloid positive MCI subjects. In the amyloid-positive group, CSF TNF-α was not associated with change in FDG over time in MCI (p > 0.05, A). However, higher CSF TNF-α levels were associated with a steeper decline in FDG SUVR in the amyloid-negative group (p < 0.05, B).
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Edwards FA. A unifying hypothesis for alzheimer’s disease: from plaques to neurodegeneration. Trends Neurosci. 2019;42(5):310–322. doi:10.1016/j.tins.2019.03.003 - DOI - PubMed
    1. Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, Lamb BT. Inflammation as a central mechanism in alzheimer’s disease. Alzheimers Dement. 2018;4:575–590. - PMC - PubMed
    1. McGeer PL, Schulzer M, McGeer EG. Arthritis and anti-inflammatory agents as possible protective factors for alzheimer’s disease: a review of 17 epidemiologic studies. Neurology. 1996;47(2):425–432. doi:10.1212/WNL.47.2.425 - DOI - PubMed
    1. Zhao M, Cribbs DH, Anderson AJ, et al. The induction of the TNFα death domain signaling pathway in alzheimer’s disease brain. Neurochem Res. 2003;28(2):307–318. doi:10.1023/A:1022337519035 - DOI - PubMed
    1. Tan Z, Beiser A, Vasan R, et al. Inflammatory markers and the risk of Alzheimer disease: the Framingham Study. Neurology. 2007;68(22):1902–1908. doi:10.1212/01.wnl.0000263217.36439.da - DOI - PubMed

LinkOut - more resources